We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
-4.45%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$3.08B
AUM Growth
+$322M
Cap. Flow
+$648M
Cap. Flow %
21%
Top 10 Hldgs %
37.4%
Holding
321
New
89
Increased
78
Reduced
45
Closed
96

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$32M
2
CCCC icon
C4 Therapeutics
CCCC
+$14.5M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$14.1M
4
AMRS
Amyris Inc.
AMRS
+$11M
5
TECH icon
Bio-Techne
TECH
+$10.3M

Top Sells

Rank Stock Value
1
NTRA icon
Natera
NTRA
+$14.1M
2
DXCM icon
DexCom
DXCM
+$14.1M
3
ICUI icon
ICU Medical
ICUI
+$14M
4
LIVN icon
LivaNova
LIVN
+$12.2M
5
OLPX
Olaplex Holdings
OLPX
+$11.6M

Sector Composition

Rank Sector Weight
1 Healthcare 24.06%
2 Materials 0.35%
3 Industrials 0.17%
4 Consumer Discretionary 0.07%
5 Financials 0.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LONA
126
LeonaBio Inc
LONA
$73.9M
$4.58M 0.15%
33,947
-13,483
-28% -$1.42M
CTKB icon
127
Cytek Biosciences
CTKB
$621M
$4.58M 0.15%
424,577
+2,800
+0.7% +$37.8K
GH icon
128
Guardant Health
GH
$22.2B
$4.53M 0.15%
68,375
-33,900
-33% -$2.32M
CLDX icon
129
Celldex Therapeutics
CLDX
$3.52B
$4.51M 0.15%
132,571
+800
+0.6% +$25.6K
UHS icon
130
PUT
Universal Health Services
UHS
$10.2B
$4.35M 0.14%
30,000
+5,300
+21% +$733K
NYXH
131
Nyxoah
NYXH
$158M
$4.3M 0.14%
221,949
+1,326
+0.6% +$26.7K
SONX
132
DELISTED
Sonendo, Inc.
SONX
$4.1M 0.13%
1,023,424
+146,039
+17% +$809K
GRNA
133
DELISTED
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
$3.85M 0.12%
+400,000
New +$3.58M
RCEL icon
134
CALL
Avita Medical
RCEL
$251M
$3.82M 0.12%
+450,000
New +$4.15M
GHRS icon
135
GH Research
GHRS
$2.08B
$3.81M 0.12%
208,527
-18,900
-8% -$334K
ARQT icon
136
Arcutis Biotherapeutics
ARQT
$3.3B
$3.65M 0.12%
189,363
+50,700
+37% +$858K
TDOC icon
137
PUT
Teladoc Health
TDOC
$1.22B
$3.61M 0.12%
+50,000
New +$3.6M
TKNO icon
138
Alpha Teknova
TKNO
$397M
$3.47M 0.11%
251,112
+1,600
+0.6% +$25.2K
IMUX icon
139
PUT
Immunic
IMUX
$217M
$3.39M 0.11%
+30,000
New +$3.47M
TGTX icon
140
TG Therapeutics
TGTX
$7.58B
$3.12M 0.1%
+328,187
New +$3.8M
INMD icon
141
PUT
InMode
INMD
$875M
$3.1M 0.1%
+84,000
New +$3.76M
LAB icon
142
Standard BioTools
LAB
$312M
$3.05M 0.1%
+850,000
New +$2.94M
ITGR icon
143
PUT
Integer Holdings
ITGR
$4.25B
$3.02M 0.1%
+37,500
New +$3.03M
ICAD
144
DELISTED
iCAD Inc
ICAD
$3M 0.1%
+672,989
New +$3.39M
UTHR icon
145
United Therapeutics
UTHR
$21.9B
$2.97M 0.1%
16,561
+5,803
+54% +$1.11M
KIDS icon
146
PUT
OrthoPediatrics
KIDS
$649M
$2.97M 0.1%
55,000
-131,900
-71% -$6.74M
TVTX icon
147
Travere Therapeutics
TVTX
$5.86B
$2.84M 0.09%
110,225
+300
+0.3% +$7.96K
BLU
148
DELISTED
BELLUS Health Inc.
BLU
$2.68M 0.09%
390,097
+2,300
+0.6% +$14.8K
IGMS
149
CALL
DELISTED
IGM Biosciences
IGMS
$2.67M 0.09%
+100,000
New +$1.86M
APEN
150
DELISTED
Apollo Endosurgery, Inc.
APEN
$2.58M 0.08%
427,057
+52,400
+14% +$319K
4 5
6
7 8

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q1 2022 Portfolio in Review

As of Q1 2022, Pura Vida Investments held 321 positions worth $3.08B, up 12% from $2.76B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Pura Vida Investments deployed $648M of net new capital in Q1 2022, opening 89 new positions and adding to 78 existing holdings. Its largest new stake was Biogen: 147,135 shares worth $31M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 30% a quarter earlier, followed by Materials and Industrials.

On the sell side, the largest reduction was ICU Medical, an estimated $14M trimmed.

  • Pura Vida Investments's largest Q1 2022 buy was Biogen: 147,135 shares worth $31M.
  • Pura Vida Investments added most to C4 Therapeutics in Q1 2022, an estimated $14.5M increase.
  • Pura Vida Investments's biggest Q1 2022 reduction was ICU Medical, cutting an estimated $14M.
  • Pura Vida Investments fully exited Natera in Q1 2022, selling an estimated $14.1M.
  • Pura Vida Investments's ten largest holdings make up 37% of its $3.08B portfolio in Q1 2022.
  • Pura Vida Investments opened 89 new positions and closed 96 in Q1 2022.
  • Pura Vida Investments's portfolio value rose 12% quarter-over-quarter to $3.08B.

Based on Pura Vida Investments's 13F filing for Q1 2022, filed 16 May 2022.